INS and type 1 diabetes mellitus: However, despite increased use of continuous glucose monitoring (CGM), continuous subcutaneous insulin infusion (CSII) and improved insulin analogues, achieving and maintaining the recommended glucose targets remains challenging for most pregnant women with type 1 diabetes [4–6].